Koyfin Home > Directory > Health Care > Apellis Pharmaceuticals Inc > Repurchase of Common Stock

Apellis Pharmaceuticals Inc Repurchase of Common Stock Chart (APLS)

Apellis Pharmaceuticals Inc annual/quarterly Repurchase of Common Stock from 2018 to 2018.
  • Apellis Pharmaceuticals Inc Repurchase of Common Stock for the quarter ending September 09, 2018 was $0m
Other Cash Flow Metrics:
  • Apellis Pharmaceuticals Inc Cash Flow from Operations for the quarter ending December 12, 2018 was $-44m a 48.43% decrease of -22m year over year
  • Apellis Pharmaceuticals Inc Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $-39m a 62.21% decrease of -24m year over year
View Chart On Koyfin

Quarterly APLS Repurchase of Common Stock Data

09/2018$0m